Photodynamic therapy for nonmelanoma skin cancers: Current review and update

Molecular Immunology

Volumn 39, Issue 17-18, 2003, Pages 1133-1136

  Zeitouni, Nathalie C ^a   Oseroff, Allan R ^a   Shieh, Sherry ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

ALA; Nonmelanoma skin cancer; Photodynamic therapy; Photofrin

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BIOAVAILABILITY; BOWEN DISEASE; CONFERENCE PAPER; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CARCINOMA; TUMOR CELL;

EID: 0038771211     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00083-X     Document Type: Conference Paper

References (48)

1. Bandieramonte G., Marchesini R., Melloni E., Andreoli C., di Pietro S., Spinelli P., Fava G., Zunino F., Emanuelli H. Laser phototherapy following HpD administration in superficial neoplastic lesions. Tumor. 70:1984;327-334.
2. Braathen L., Paredes B., Frölich K.et al. A dose-finding study of photodynamic therapy (PDT) with Metvix™ in actinic keratoses (AK). J. Eur. Acad. Dermatol. Venereol. 14:2000;38.
3. Buchanan R.B., Carruth J.A.S., McKenzie A.L.et al. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur. J. Surg. Oncol. 15:1989;400-406.
4. Cai W.M., Yang Y., Zhang N.W., Xie G., Zhang X., Fan X.J., Shen H., Hu X.J., Ha X.W. Photodynamic therapy in the management of cancer: an analysis of 114 cases. Adv. Exp. Med. Biol. 193:1985;13-19.
5. Cairnduff F., Stringer M.R., Hudson E.J. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer. 69:1994;605-608.
6. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical α-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J. Photochem. Photobiol. B. 29:1995;53-57.
7. Cox N.H., Eedy D.J., Morton C.A. Guidelines for management of Bowen's disease. Br. J. Dermatol. 141:1999;633-641.
8. Dougherty T.J. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. J. Clin. Laser Med. 14:1996;219-221.
9. Dougherty T.J., Kaufman J.E., Goldfarb A.et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 38:1978;2635.
10. Dougherty T.J., Gomer C.J., Henderson B.W.et al. Photodynamic therapy. J. Natl. Cancer Inst. 90:1998;889-905.
11. Feyh J., Goetz A., Muller W. Photodynamic therapy in head and neck surgery. Photochem. Photobiol. 7:1990;353-358.
12. Fijan S., Honigsmann H., Ortel B. photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br. J. Dermatol. 113:1995;282-288.
13. Fink-Puches R., Hofer A., Smolle J.et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J. Photochem. Photobiol. B. 41:1997;145-151.
14. Fink-Puches R., Soyer H.P., Hofer A. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical δ-aminolevulinic acid photodynamic therapy. Arch. Dermatol. 134:1998;821-826.
15. Fisher A.M.R., Murphree A.L., Gomer C.J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17:1995;2-31.
16. Gross D.J., Waner M., Schosser R.H., Dinehart S.M. Squamous cell carcinoma of the lower lip involving a large cutaneous surface. Arch. Dermatol. 126:1990;1148-1150.
17. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
18. Hintschich C., Feyh J., Beyer-Machule C. Photodynamic laser therapy of basal cell carcinoma of the lid. Ger. J. Ophthalmol. 2:1993;212-217.
19. Jeffes E.W., McCullough J.L., Weinstein G.D.et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. Arch. Dermatol. 133:1997;727-732.
20. Jones C.M., Mang T., Cooper M.et al. Photodynamic therapy in the treatment of Bowen's disease. J. Am. Acad. Dermatol. 27:1992;979-982.
21. Keller G.S., Razum N.J., Doiron D.R. Photodynamic therapy for nonmelanoma skin cancer. Facial Plast. Surg. 124:1989;211-216.
22. Kennedy, J., 1983. HPD photoradiation therapy for cancer at Kingston and Hamilton. In: Kessel, D., Dougherty, T.J. (Eds.), Porphyrin Photosensitization. Plenum Press, New York, pp. 53-62.
23. Kennedy J.D., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol. 6:1990;143-148.
24. Kubler A.C., Haase T., Staff C., Kahle B., Rheinwald M., Muhling J. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg. Med. 25:1999;60-68.
25. Lui H., Salasche S., Kollias N. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. Arch. Dermatol. 131:1995;737-738.
26. Meijnders P.J.N., Star W.M., De Bruijn R.S.et al. Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolaevulinic acid. Lasers Med. Sci. 11:1996;123-131.
27. Morton C.A. 5-ALA matches 5-FU in Tx of Bowen's disease. Dermatol. Times. 21:2000;23.
28. Morton C.A., Whitehurst C., Mosley H.et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br. J. Dermatol. 135:1996;766-771.
29. Pennington D.G., Waner M., Knox A. Photodynamic therapy for multiple skin cancers. Plast. Reconstr. Surg. 82:1987;1067-1071.
30. Petrelli N.J., Cebollero J.A., Rodriguez-Bigas M., Mang T. Photodynamic therapy in the management of neoplasms of the perianal skin. Arch. Surg. 127:1992;1436-1438.
31. Rhodes L.E., Tsoukas M.M., Anderson R.R., Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J. Invest. Dermatol. 108:1997;87-91.
32. Robinson P.J., Carruth J.A.S., Fairris G.M. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br. J. Dermatol. 119:1988;59-61.
33. Soler A.M., Warloe T., Berner A., Giercksky K.E. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br. J. Dermatol. 145:2001;467-471.
34. Stables G.I., Stringer M.R., Robinson D.J.et al. The treatment of Bowen's disease by topical aminolevulinic acid photodynamic therapy. Br. J. Dermatol. 139(Suppl. 51):1998;74.
35. Stefanidou M., Tosca A., Themlis G., Vazgiouraki E., Balas C. In vivo fluorescence kinetics and photodynamic therapy efficacy of α-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses implications for optimization of photodynamic therapy. Eur. J. Dermatol. 10:2000;351-356.
36. Szeimies R.M., Karrer S., Sauerwald A.et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology. 192:1996;246-251.
37. Thissen M.R.T.M., Schroeter C.A., Neumann H.A.M. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br. J. Dermatol. 142:2000;338-339.
38. Tomio, L., Calzavara, F., Zorat, P.L., et al., 1984. Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin. In: Doiron, D.R., Gomer, C.J. (Eds.), Porphyrin Localization and Treatment of Tumor. Liss, New York, pp. 829-840.
39. Tse D.T., Kersten R.C., Anderson R.L. Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report. Arch. Ophthalmol. 102:1984;990-994.
40. Waldow S.M., Lobraico R.V., Kohler I.K.et al. Photodynamic therapy for treatment of malignant cutaneous lesions. Lasers Surg. Med. 7:1987;451-456.
41. Wang I., Bauer B., Andersson-Engels S. Photodynamic therapy utilizing topical δ-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Opthalmol. Scand. 77:1999;182-188.
42. Warloe, T., Peng, Q., Moan, J., et al., 1992. Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In: Spinelli, P., Fante, M.D., Marhesini, R. (Eds.), Photodynamic Therapy and Biomedical Lasers. Elsevier, Amsterdam, pp. 449-453.
43. Warloe T., Heyerdahl H., Peng Q., Giercksky K.E. Photodynamic therapy with 5-aminolaevulinic acid induced porphyrins and skin penetration enhancer for basal cell carcinoma. SPIE. 2371:1994;226-235.
44. Wilson B.D., Mang T.S., Cooper M. Use of photodynamic therapy for treatment of extensive basal cell carcinomas. Facial Plast. Surg. 6:1989;185-189.
45. Wilson B.D., Mang T.S., Stoll H., Jones C., Cooper M., Dougherty T.J. Photodynamic therapy for the treatment of basal cell carcinoma. Arch. Dermatol. 128:1992;1597-1601.
46. Wolf P., Kerl H. Photodynamic therapy in a patient with xeroderma pigmentosum. Lancet. 337:1991;1613-1614.
47. Wolf P., Rieger E., Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas. J. Am. Acad. Dermatol. 28:1993;17-21.
48. Zeitouni, N.C., Shieh, S., Oseroff, A.R., 2001. Laser and Photodynamic therapy in the management of cutaneous malignancies. In: Ellerin, B. (Ed.), Clinics in Dermatology. Elsevier, New York, NY, pp. 328-339.